Seattle Genetics, Inc. announced two executive promotions and an executive appointment to the company’s clinical development leadership team. Vaughn B. Himes has been promoted to chief technical officer. In this new role, he will oversee Seattle Genetics’ process sciences, manufacturing, supply chain, quality assurance and quality control functions. Dennis Benjamin has been promoted to senior vice president, Translational Research. Dr. Benjamin will be responsible for preclinical research, nonclinical sciences and experimental pharmacology. Seattle Genetics also named Robert J. Lechleider as senior vice president, Clinical Development. Dr. Lechleider will oversee all clinical development programs within the company’s therapeutic focus areas of lymphoma, leukemia, solid tumors, and immuno-oncology, as well as translational medicine and biometrics. Vaughn B. Himes joined Seattle Genetics in April 2009, bringing more than twenty years of experience in manufacturing, technical operations, process development and scale-up activities. Vaughn B. Himes most recently served as executive vice president, Process Sciences and Technical Operations. Prior to joining Seattle Genetics, Dr. Himes was with ZymoGenetics as senior vice president, Technical Operations, where his responsibilities included commercial and clinical manufacturing, supply chain and logistics, quality control and process development. Dennis Benjamin joined Seattle Genetics in December 2004, starting as Director of Biochemistry and working his way through various positions within research to his current role as senior vice president, Translational Research. Prior to joining Seattle Genetics, he held research positions at Praecis Pharmaceuticals and Genetics Institute. Robert J. Lechleider recently joined Seattle Genetics as Senior Vice President, Clinical Development. Previously, Dr. Lechleider held key roles at several biopharmaceutical companies, including MacroGenics and MedImmune. Before joining the biotechnology industry, he served as Assistant Professor of Pharmacology at Uniformed Services University of the Health Sciences, and Associate Professor of Cell Biology at Georgetown University Medical School.